Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis

European Journal of Neurology

Volumn 4, Issue 1, 1997, Pages 59-67

  Sellebjerg, F ^a   Bendtzen, K ^b   Christiansen, M ^c   Frederiksen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Autoimmune disease; Cytokines; Multiple sclerosis (MS); Optic neuritis (ON)

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; FEMALE; HELPER CELL; HUMAN; LYMPHOCYTE ACTIVATION; MALE; MULTIPLE SCLEROSIS; OPTIC NERVE DISEASE; PRIORITY JOURNAL;

EID: 0031020579     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1997.tb00300.x     Document Type: Article

References (49)

1. Adachi K, Kumamoto T and Araki S (1990) Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. Annals of Neurology, 28, 687-691.
2. Baumann H and Gauldie J (1994) The acute phase response. Immunology Today, 15, 74-80.
3. Bendtzen K (1994) Cytokines and natural regulators of cytokines. Immunology Letters, 43, 111-123.
4. Bendtzen K, Hanse MB, Ross C, Poulsen LK and Svenson M (1995) Cytokines and autoantibodies to cytokines. Stem Cells, 13, 206-222.
5. Benveniste EN, Sparacio SM, Norris JG, Grenett HE and Fuller GM (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. Journal of Neuroimmunology, 30, 201-212.
6. Benvenuto R, Paroli M, Buttinelli C, Franco A, Barnaba V, Fieschi C and Balsano F (1991) Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T-cell clones from patients with multiple sclerosis. Clinical and Experimental Immunology, 84, 97-102.
7. Brod SA, Benjamin D and Hafler DA (1991) Restricted T-cell expression of II-2/IFN-gamma mRNA in human inflammatory disease. Journal of Immunology, 47, 810-815.
8. Cannella B and Raine CS (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Annals of Neurology, 37, 424-435.
9. Christiansen M, Høgdall CK and Brihmer C (1995) Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system. Clinica Chimica Acta, 235, 71-79.
10. Correale J, McMillan M, McCarthy K, Le T and Weiner LP (1995) Isolation and characterization of autoreactive proteolipid protein-peptide specifc T-cell clones from multiple sclerosis patients. Neurology, 45, 1370-1378.
11. Deckert-Schlüter M, Schlüter D and Schwendemann G (1992) Evaluation of IL-2, sIL2R, IL-6, TNF-alpha, and IL-I-beta in serum and CSF of patients with optic neuritis. Journal of Neurological Science, 113, 50-54.
12. Ebers GC (1985) Optic neuritis and multiple sclerosis. Archives of Neurology, 42, 702-704.
13. Frederiksen JL, Larsson HB, Olesen J and Stigsby B (1991) MRI, VEP, SEP, and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurologica Scandinavica, 83, 343-350.
14. Frei K, Fredrikson S, Fontana A and Link H (1991) Interleukin-6 is elevated in plasma in multiple sclerosis. Journal of Neuroimmunology, 31, 147-153.
15. Gallo P, Piccinno MG, Pagni S, Argentiero V, Giometto B, Bozza F and Tavolato B (1989) Immune activation in multiple sclerosis: study of I1-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid. Journal of Neurological Science, 92, 9-15.
16. Gallo P, Piccinno MG, Tavolato B and Siden A (1991) A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum. Journal of Neurological Science, 101, 227-232.
17. Gallo P. Piccinno M, Pagni S and Tavolato B (1988) Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Annals of Neurology, 24, 795-797.
18. Garrone P, Djossou O, Galizzi J and Banchereau J (1991) A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. European Journal of Immunology, 21, 1365-1469.
19. Hansen MB, Svenson M and Bendtzen K (1991) Human anti-interleukin-alpha antibodies. Immunology Letters, 30, 133-140.
20. Hauser SL, Doolittle TH, Lincoln R, Brown RH and Dinarello CA (199) Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology, 40, 1735-1739.
21. Heaney ML and Golde DW (1996) Soluble cytokine receptors. Blood, 87, 847-857.
22. Hofman FM, Hinton DR, Johnson K and Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. Journal of Experimental Medicine, 170, 607-612.
23. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D and Merrill JE (1986) Immunoregulatory molecules and I1 2 receptors identified in multiple sclerosis brain. Journal of Immunology, 136, 3239-3245.
24. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology, 43, 655-661.
25. Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Pantich HS, Rose JW, Schiffer RB, and the Copolymer 1 Multiple Sclerosis Study Group (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. Neurology, 45, 1268-1276.
26. + T-cells in the pathogenesis of organ-specific autoimmune diseases. Immunology Today, 16, 34-38.
27. Link J, Söderström M, Olsson T, Höjeberg B, Ljungdahl Å and Link H (1993) Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Annals of Neurology, 36, 379-386.
28. Lu CZ, Jensen MA and Arnason BG (1993) Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. Journal of Neuroimmunology, 46, 123-128.
29. Maimone D, Gregory S, Arnason BG and Reder AT (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. Journal of Neuroimmunology, 32, 67-74.
30. Navikas V, Link J, Palasik W, Soderstrom M, Fredrikson S, Olsson T and Link H (1995) Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scandinavian Journal of Immunology, 41, 171-178.
31. Olsson T (1994) Role of cytokines in multiple sclerosis and experiemental autoimmune encephalomyelitis. European Journal of Neurology, 1, 7-10.
32. Panitch HS, Hursch RL, Schindler J and Johnson KP (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology, 37, 1097-1102.
33. Perkin GD and Rose FC (1979) Optic Neuritis and its Differential Diagnosis. Oxford, Oxford University Press.
34. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH and Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology, 13, 227-231.
35. Rajan N. Tsarbopoulos A, Kumarasamy R, O'Donnell R, Taremi SS, Baldwin SW, Seelig GH, Fan X, Pramanik B and Le HV (1995) Characterization of recombinant human interleukin 4 receptor from CHO cells: role of N-linked oligosaccharides. Biochemistry and Biophysical Research Communications, 206, 694-702.
36. Romagnani S (1995) Biology of human Th1 and Th2 cells. Journal of Clinical Immunology, 15, 121-129.
37. Salmaggi A, Dufour A, Eoli M, Corsini E, La Mantia L, Massa G, Nespolo A and Milanese C (1996) Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic ummunosuppression. Journal of Neurology, 243, 13-17.
38. Selmaj K, Raine CS, Cannella B and Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. Journal of Clinical Investigations, 87, 949-954.
39. Sharief MK and Thompson EJ (1992) In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. Journal of Neuroimmunology, 38, 27-33.
40. Sharief MK and Thompson EJ (1993) Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 56, 169-174.
41. de Simoni MG, de Luigi A, Gemma L, Sironi M, Manfridi A and Ghezzi P (1993) Modulation of systemic interleukin-6 induction by central interleukin-1. American Journal of Physiology, 265, R739-R742.
42. Tomioka R, Hamaguchi K, Ohno R, Hosokawa T, Kaneko A, Tsuji T and Kurihara K (1992) Elevated interleukin 2 levels in serum and cerebrospinal fluid of paitents with relapsing-remitting multiple sclerosis. Annals of the New York Academy of Science, 347-350.
43. Traugott U and Lebon P (1988) Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. Journal of Neurological Science, 84, 257-264.
44. Trotter JL, Damico CA, Trotter AL, Collins KG and Cross AH (1995) Interleuikin-2 binding proteins in sera from normal subjects and multiple sclerosis patients. Neurology, 45, 1971-1974.
45. Tsukada N, Miyagi M, Matsuda M, Yanagisawa N and Yone K (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. Journal of Neurological Science, 102, 230-234.
46. Vilcek J and Le J (1994) Immunology of citykines: an introduction In: The Cytokine Handbook Thompson A (Ed) 2nd edn, pp. 1-19. London, Academic Press.
47. Weller M, Stevens A, Sommer N, Melms A, Dichgans J and Wiethölter H (1991) Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. Journal of Neurological Science, 104, 215-221.
48. Woodroofe MN and Cuzner ML (1991) Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine, 5, 583-588.
49. Wucherpfennig KW, Newcombe J, Li H, Keddy C, Cuzner ML and Hafler DA (1992) T-cell receptor alpha-Vbeta repertoire and cytokine gene expression in active multiple sclerosis lesions. Journal of Experimental Medicine, 175, 993-1002.